Not Your Typical Mesothelioma Patient
By: Tamron Little I like to think back 14 years ago that if someone would have told me that I was going to have cancer, I would have probably…
Continue Reading
Not Your Typical Mesothelioma Patient
source: pixabay.com
Scientists Discover That a Blood Pressure Medication Can Increase Immune-Boosting Cells
According to a recent article in Genetic Engineering News, findings by scientists at the University of Boston’s School of Medicine and Massachusetts General Hospital (MGH) have uncovered two plausible…
Continue Reading
Scientists Discover That a Blood Pressure Medication Can Increase Immune-Boosting Cells
source: pixabay.com
Follicular Lymphoma: Therapy Sequencing in Relapsing/Remitting Disease
In a video conversation recorded for Cancer Network, Kristie L. Kahl and Javier L. Munoz, MD, MS, FACP discussed treatment for relapsing/remitting follicular lymphoma and the importance of the sequencing…
Continue Reading
Follicular Lymphoma: Therapy Sequencing in Relapsing/Remitting Disease
Help Is On The Way With A Blood Test That Can Detect 50 Types of Cancer
An exciting article in the Guardian published last year and a confirming article published this month state that new diagnostic technology has shown ‘impressive results’. This test can spot tumors…
Continue Reading
Help Is On The Way With A Blood Test That Can Detect 50 Types of Cancer
source: pixabay.com
New Partnership to Develop Biotherapies for Cancer
Some good news was reported recently in a Biospace article. Dana-Farber Cancer Institute and Harbour BioMed have agreed to combine resources and co-develop novel biotherapies for oncology and immunological…
Continue Reading
New Partnership to Develop Biotherapies for Cancer
Next Generation Sequencing Leads to New Options When Standard Treatments Fail
No longer the new player on the team, next-generation sequencing (NGS) is well established as having an influence in clinical care. In recent years, NGS has been responsible for many…
Continue Reading
Next Generation Sequencing Leads to New Options When Standard Treatments Fail
source: pixabay.com
Study of the Week: Using CRISPR to Investigate Cancer Cell Division
Welcome to Study of the Week from Patient Worthy. In this segment, we select a study we posted about from the previous week that we think is of particular interest…
Continue Reading
Study of the Week: Using CRISPR to Investigate Cancer Cell Division
New Study Determines Risk Factors for Osteonecrosis of The Jaw
A new study published in JAMA Oncology has found that of all patients who have had cancer spread to their bones and started treatment, 2,8% have developed osteonecrosis within their jaw, also…
Continue Reading
New Study Determines Risk Factors for Osteonecrosis of The Jaw
Genetic Screenings and the Problems That Arise
Genetic testing is being used more frequently to screen people for the hereditary risk of cancer, according to MedCity News. While advancements have been made and research is ongoing, there…
Continue Reading
Genetic Screenings and the Problems That Arise
source: pixabay.com
Study Shows History of Venous Thromboembolism Causes Increased Risk of Thrombosis Following Cancer Treatment
A recent study has found that there is an increased risk of developing recurring thrombosis for cancer patients who have a history of venous thromboembolism, or VTE. The results of…
Continue Reading
Study Shows History of Venous Thromboembolism Causes Increased Risk of Thrombosis Following Cancer Treatment
source: pixabay.com
This Drug Could be Effective Against Tumors with a Rare Mutation
According to a story from Medscape, in a recent study the drug capivasertib appeared to be effective as a treatment for certain metastatic cancer tumors. Classified as an inhibitor of…
Continue Reading
This Drug Could be Effective Against Tumors with a Rare Mutation
source: pixabay.com
A Surgery To Treat Obesity Found to Significantly Lower Risk of Pancreatic Cancer
According to EMJ, findings from an analysis spanning 20 years has found that weight loss surgery used to address obesity also significantly lowers a person's risk of developing pancreatic cancer.…
Continue Reading
A Surgery To Treat Obesity Found to Significantly Lower Risk of Pancreatic Cancer
CRISPR-Cas9’s Gene Editing Potential in Cancer Therapy
Toxicity resulting from cancer therapy is usually the result of the repeated administration of cancer drugs. On the other hand, the efficacy of CRISPR-Cas9 has been largely affected by problematic…
Continue Reading
CRISPR-Cas9’s Gene Editing Potential in Cancer Therapy
source: pixabay.com
Study Finds Better Way to Visualize PET Scan Results
Researchers have uncovered a new way to treat cancer that could lessen the side effects that patients often experience from chemotherapy. At the same time, it improves the curative power…
Continue Reading
Study Finds Better Way to Visualize PET Scan Results
Christmas Came Early for One Family: Boy Beats Rare Brain Cancer
Meet Cameron Scott, eight-year-old superhero who has been declared free from his stage 4 brain cancer! Specifically, Cameron was diagnosed with medulloblastoma, a rare high-risk tumor which spread to his…
Continue Reading
Christmas Came Early for One Family: Boy Beats Rare Brain Cancer
source: pixabay.com
FDA Approves PSMA PET Technique for Prostate Cancer from UCLA and UCSF
According to Newswise, the FDA recently approved a new prostate cancer imaging technique developed by researchers at UCLA and UCSF. The imaging technique, called prostate-specific membrane antigen PET imaging (PSMA…
Continue Reading
FDA Approves PSMA PET Technique for Prostate Cancer from UCLA and UCSF
Researchers Have Uncovered a More Specific Method to Diagnose Breast Cancer
We all know that diagnosing cancer earlier means better outcomes for patients. It’s also essential to monitor the spread of cancer in already diagnosed patients. If we can watch as…
Continue Reading
Researchers Have Uncovered a More Specific Method to Diagnose Breast Cancer
source: pixabay.com
Tel Aviv University Team Uses CRISPR Technique to Destroy Metastatic Cancer Cells in Mice
The latest news from Israeli scientists, published in the Times of Israel, is that researchers at Tel Aviv University have accurately targeted cancerous cells in mice using CRISPR.…
Continue Reading
Tel Aviv University Team Uses CRISPR Technique to Destroy Metastatic Cancer Cells in Mice
Twist Bioscience Gives Impressive Presentation at the Virtual American Society for Human Genetics 2020 Annual Conference
A recent article in BioSpace highlighted presentations by Twist Bioscience, a rapidly growing genomic and synthetic biology company. Twist presented its product line at the virtual 2020 Annual Meeting of…
Continue Reading
Twist Bioscience Gives Impressive Presentation at the Virtual American Society for Human Genetics 2020 Annual Conference
source: pixabay.com
New Combination for HRD-Positive Ovarian Cancer Gets EU Approval
According to a story from Cancer Network, the European Commission has recently approved a two-part combination treatment for advanced, homologous recombination deficiency (HRD)-positive ovarian cancer. This first-line maintenance treatment consists…
Continue Reading
New Combination for HRD-Positive Ovarian Cancer Gets EU Approval
source: pixabay.com
CAR-T Therapy for Multiple Myeloma Trial Marred by Patient Death
According to Biospace, Allogene's trial of ALLO-715 for relapsed/refractory multiple myeloma was marred by a patient death. Data from this trial is slated to be presented in December at the…
Continue Reading
CAR-T Therapy for Multiple Myeloma Trial Marred by Patient Death
Next Generation Sequencing (NGS) is Highly Recommended for Relatives of Cancer Patients
DNA sequencing has become part of our lives - but what is it? For one thing, it is a big business. In 2003, approximately $3billion US found its way into…
Continue Reading
Next Generation Sequencing (NGS) is Highly Recommended for Relatives of Cancer Patients
Andrew Krivoshik, M.D., Ph.D., was promoted to senior vice president and Oncology Therapeutic Area Head on April 1, 2019
Astellas Pharma Provides Help, Guidance, and Hope for Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)
Astellas Pharma, headquartered in Northbrook, Illinois presents its Be R/Ready program to promote patient-physician communication as well as other valuable and informative resources. Their program centers around patients with relapsed…
Continue Reading
Astellas Pharma Provides Help, Guidance, and Hope for Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)
New Website Pushes for Pancreatic Cancer Awareness
Pancreatic cancer is a rare but severe cancer, and it is often difficult to diagnose until it has advanced. When you combine this with a lack of knowledge and awareness…
Continue Reading
New Website Pushes for Pancreatic Cancer Awareness
source: pixabay.com
Tumor Biopsy Sequencing Helps Select Targeted Treatments in New Study
According to a story from Medscape, a recent large scale trial focused on cancer treatment has produced some interesting results. The trial was aimed at testing next generation sequencing of…
Continue Reading
Tumor Biopsy Sequencing Helps Select Targeted Treatments in New Study
- Go to the previous page
- 1
- …
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- …
- 21
- Go to the next page
